乳腺癌保乳手术联合术中放疗适应证研究进展

摘要
图/表
参考文献(35)
相关文章 (15)

全文: PDF (569 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要乳腺癌是居全球女性发病率前列的恶性肿瘤之一，临床常用的全乳腺切除的手术方式，对患者的心理和美容造成很大影响。保乳手术（BCS）联合术中放射治疗（IORT），由于减少了放射治疗周期和周围正常组织放射剂量，同时又保持了良好的肿瘤治疗特异性和较好的美容效果，因此保乳手术联合术中放疗得到了国际上的支持。但是，在IORT患者的选择方面，存在多个意见，但是并未达成共识，甚至其中一些提出了相互矛盾的观点。笔者就乳腺癌保乳手术联合术中放疗适应证相关研究进行综述。以便为临床医生的医疗决策提供借鉴和参考。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	王子祥吴爱国▲

关键词 ：乳腺癌, 保乳手术, 术中放疗, 局部复发

Abstract：Breast cancer is the most common disease in women worldwide, the whole-mammectomy surgery greatly effects on the patients′ psychological and beauty. Breast-conserving surgery (BCS) combined intraoperative radiotherapy (IORT) gained international favor because of its reduction in treatment duration, decreased irradiation of healthy organs, and maintain favorable cancer-specific and better cosmetic outcomes. However, in terms of selecting patients, multiple opinions existed, even some with conflicting recommendations. In this review, the existing patient selection guidelines are summarized and compared, in order to provide reference for clinical doctors′ medical decision-making.

Key words： Breast cancer Breast-conserving surgery Intraoperative radiotherapy Local recurrence

通讯作者: ▲通讯作者

引用本文:

王子祥吴爱国▲. 乳腺癌保乳手术联合术中放疗适应证研究进展[J]. 中国医药导报, 2018, 15(15): 38-42.
WANG Zixiang WU Aiguo▲. Progress of breast-conserving surgery combine intraoperative radiotherapy indication for breast cancer. 中国医药导报, 2018, 15(15): 38-42.

链接本文:

http://www.yiyaodaobao.com.cn/CN/ 或 http://www.yiyaodaobao.com.cn/CN/Y2018/V15/I15/38

[1] Desantis CE，Bray F，Ferlay J，et al. International Variation in Female Breast Cancer Incidence and Mortality Rates [J]. Cancer Epidemiol Biomarkers Prev，2015，24（10）：1495-1506.
[2] 陈万青，郑荣寿.中国女性乳腺癌发病死亡和生存状况[J].中国肿瘤临床，2015，42（13）：668-674.
[3] 姜军.乳腺癌综合治疗——乳腺癌外科治疗理念的发展及启示[J].中国实用外科杂志，2011，31（10）：920-922.
[4] 曹志刚，杨雪娇，呼晓，等.保乳手术与根治术对乳腺癌患者术后乳房美观及生活质量的影响[J].中国医疗美容，2017，7（1）：21-23.
[5] van Maaren MC，de Munck L，de Bock GH，et al. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands：a population-based study [J]. Lancet Oncol，2016，17（8）：1158-1170.
[6] LeMaster TJ，Madhavan SS，MBA，Sambamoorthi U，et al. Disparities in the Initial Local Treatment of Older Women with Early-Stage Breast Cancer：A Population-Based Study [J]. J Women’s Health，2017，26（7）：735-744.
[7] 高艳，李先明，钟鹤立，等.乳腺癌保乳术后俯卧位与仰卧位放疗危及器官剂量比较的Meta分析[J].肿瘤防治研究，2015，42（9）：905-910.
[8] Deneve JL，Hoefer RA，Harris EE，et al. Accelerated Partial Breast Irradiation：A Review and Description of an Early North American Surgical Experience With the Intrabeam Delivery System [J]. Cancer Control，2012，19（4）：295-308.
[9] Keshtgar MR，Williams NR，Bulsara M，et al. Objective assessment of cosmetic outcome after targeted intraoperative radiotherapy in breast cancer：results from a randomised controlled trial [J]. Breast Cancer Res Treat ，2013，140（3）：519-525.
[10] Dutta SW ，Showalter SL，Showalter TN，et al. Intraoperative radiation therapy for breast cancer patients：current perspectives [J]. Breast Cancer-Targets and Therapy，2017， 9：257-263.
[11] Bijker N，Peterse JL，Duchateau L，et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ：analysis of European Organization for Research and Treatment of Cancer Trial 10853 [J]. J Clin Oncology，2001，19（8）：2263-2271.
[12] Wapnir IL，Dignam JJ，Fisher B，et al. Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24Randomized Clinical Trials for DCIS [J]. J Natl Cancer Inst，2011， 103（22）：478-488.
[13] Fisher ER，Anderson S，Tan-Chiu E，et al. Fifteen-Year Prognostic Discriminants for Invasive Breast Carcinoma [J]. Cancer，2001，91（8）：1679-1687.
[14] Ott OJ，Hildebrandt G，Pötter R，et al. Accelerated partial breast irradiation with interstitial implants：risk factors associated with increased local recurrence [J]. Int J Radiat Oncol Biol Phys，2011，80（5）：1458-1463.
[15] Wang X，Liu，JQ，Wang WY，et al. Clinical analysis of intraoperative radiotherapy during breast-conserving surgery of early breast cancer in the Chinese Han population [J]. Oncotarget，2015，6（40）：43120-43125.
[16] Kawamura M，Itoh Y，Sawaki M，et al. A phase Ⅰ/Ⅱ trial of intraoperative breast radiotherapy in an Asian population：5-year results of local control and cosmetic outcome [J]. Radiat Oncol，2015，10：1-6.
[17] Wolmark N，Curan WJ，Vicini F，et al. NASBP Protocol B-39（RTOG Protocol 0413）： a randomized phase III study of conventional whole breast irradiation （WBI） versus partial breast irradiation （PBI） for women with stage 0，I，or II breast cancer [database on the Internet]. 2013. Available from：http：//rpc.mdanderson.org/rpc/credentialing/NSABP/B39_Protocol1.pdf. Accessed Dec.25，2017.
[18] Moran MS，Schnitt SJ，Giuliano AE，et al. Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages Ⅰ and Ⅱ Invasive Breast Cancer [J]. Int J Radiat Oncol Biol Phys，2014，88（3）：553-564.
[19] Cefaro GA，Genovesi D，Marchese R，et al. Predictors of local recurrence after conservative surgery and whole-breast irradiation [J]. Breast Cancer Res Treat，2006，98（3）：329-335.
[20] Shah C，Vicini F,Shaitelman SF，et al. The American Brachytherapy Society consensus statement for accelerated partial-breast irradiation [J]. Brachytherapy，2018，17（1）：154-170.
[21] The American Society of Breast Surgeons：Consensus Statement for Accelerated Partial Breast Irradiation [database on the Internet]. 2011. Available from：https：//www.breastsurgeons.org/new_layout/about/statements/PDF_Statements/APBI.pdf. Accessed Jan.15，2018.
[22] Polgar C，Van Limbergen E，Potter R，et al. Patient selection for accelerated partial-breast irradiation （APBI） after breast-conserving surgery：recommendations of the Groupe Europeen de Curietherapie-European Society for Therapeutic Radiology and Oncology （GEC-ESTRO） breast cancer working group based on clinical evidence [J]. Radiother Oncol，2010，94（3）：264-273.
[23] 冯立民，朱世光，孙宪春，等.乳腺癌保留乳房手术切缘阳性的临床病理学因素分析[J].中国现代普通外科进展. 2007，10（6）：479-481.
[24] McCormick B，Winter K，Hudis C，et al. RTOG 9804：A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation [J]. J Clin Oncol，2015，33（7）：709-715.
[25] 万明辉，伍锐，潘凌霄，等.术中放疗在早期乳腺癌保乳治疗中的临床应用[J].南通大学学报：医学版，2017，37（3）：203-205.
[26] Vaidya JS，Wenz F，Bulsara M，et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer： 5-year results for local control and overall survival from the TARGIT-A randomised trial [J]. Lancet，2014，383（9917）：603-613.
[27] Vaidya JS，Bulsara M，Wenz F，et al. Pride，Prejudice，or Science：Attitudes Towards the Results of the TARGIT-A Trial of Targeted Intraoperative Radiation Therapy for Breast Cancer [J]. Int J Radiat Oncol Biol Phys，2015，92（3）：491-497.
[28] Zietman A. Letters Regarding the TARGIT-A Trial：The Editor's Introduction[J]. Int J Radiat Oncol Biology Physics，2015，92（5）：951-952.
[29] Kolberg HC，Loevey G，Akpolat-Basci L，et al. Targeted intraoperative radiotherapy tumour bed boost during breast-conserving surgery after neoadjuvant chemotherapy [J]. Strahlentherapie Onkologie，2017，193（1）：62-69.
[30] Petit JY，Veronesi U，Orecchia R，et al. Risk factors associated with recurrence after nipple-sparing mastectomy for invasive and intraepithelial neoplasia[J]. Ann Oncol，2012，23（8）： 2053-2058.
[31] Munhoz AM，Montag E，Gemperli R. Oncoplastic breast surgery：indications，techniques and perspectives [J]. Gland Surg，2013，2（3）：143-157.
[32] Belletti B，Vaidya JS，D'Andrea S，et al. Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding [J]. Clin Cancer Res，2008，14（5）：1325-1332.
[33] Vaidya JS，Bulsara M，Wenz F，et al. The lower non-breast cancer mortality with TARGIT in the TARGIT-A trial could be a systemic effect of TARGIT on tumor microenvironment [J]. Radiat Oncol Biol Phys，2013，87（2）：S240.
[34] 叶熹罡，潘凌霄，陈伦，等.术中放疗在乳腺癌保留乳头乳晕复合体乳房再造术中的应用[J].重庆医学.2015， 44（8）：1109-1111.
[35] Galimberti V，Ciocca M，Leonardi MC，et al. Is Electron Beam Intraoperative Radiotherapy （ELIOT） Safe in Pregnant Women with Early Breast Cancer? In Vivo Dosimetry to Assess Fetal Dose [J]. Ann Surg Oncol，2009，16（1）：100-105.